Application
영진바이오크롬의 자료를 제공합니다.
번호 | 분류 | 제목 | 작성일 | 첨부파일 |
---|---|---|---|---|
89 | 의약품 | Rebamipide (KP, 2-Amino-3- 2[(1H)-quinolinone-4-yl] propionate·2HCl) | 2025-01-10 | |
88 | 의약품 | Naproxen Sodium Tablets (KP, Assay) | 2025-01-10 | |
87 | 의약품 | Simvastatin (USP, Impurity) | 2025-01-10 | |
86 | 의약품 | Betadex (USP, Assay) | 2025-01-10 | |
85 | 의약품 | Pseudoephedrine HCl + Triprolidine HCl tablets (USP, Assay) | 2025-01-10 | |
84 | 의약품 | Esomeprazole Magnesium Delayed-Release Capsules (USP, Impurity) | 2025-01-10 | |
83 | 의약품 | L-Arginine-L-aspartate solution (KP, Assay) | 2025-01-10 | |
82 | 의약품 | Olopatadine Hydrochloride (USP, Limit of Early Eluting Impurities) | 2025-01-10 | |
81 | 의약품 | Olopatadine Hydrochloride (USP, Limit of Late Eluting Impurities) | 2025-01-10 | |
80 | 의약품 | Olopatadine Hydrochloride (USP, Assay) | 2025-01-10 | |
79 | 의약품 | Gabapentin Tablets (Dissolution) | 2025-01-10 | |
78 | 의약품 | Buspirone HCl Tablets(USP, Related substances) | 2025-01-10 | |
77 | 의약품 | Buspirone HCl Tablets (USP, Assay) | 2025-01-10 | |
76 | 의약품 | Cisplatin injection (Assay) | 2025-01-10 | |
75 | 의약품 | Chlorpheniramine maleate (KP, Related substances) | 2025-01-10 |